Global prevalence of hepatitis C virus in children in 2018: a modelling study
Jonathan Schmelzer(Center for Disease Analysis), Manal H. El‐Sayed(Ain Shams University), Chris Estes(Center for Disease Analysis), Sarah Robbins-Scott(Center for Disease Analysis), Ivane Gamkrelidze, Mindi DePaola(Center for Disease Analysis), Kathryn Jerabek(Center for Disease Analysis), Devin Razavi‐Shearer(University of London), Shauna Montoya(Center for Disease Analysis), Homie Razavi(Center for Disease Analysis), Sarah Blach(Center for Disease Analysis), Kathryn Razavi‐Shearer(Center for Disease Analysis), Siyi Ma(East China University of Science and Technology), Samantha Coleman(University College London), Ellen Dugan(Center for Disease Analysis), Zongzhen Cai(Center for Disease Analysis)
Cited by 123
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises
|The Lancet|2020|1.9k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399